Quantcast
ZME Science
  • CoronavirusNEW
  • News
  • Environment
    • Climate
    • Animals
    • Renewable Energy
    • Eco tips
    • Environmental Issues
    • Green Living
  • Health
    • Alternative Medicine
    • Anatomy
    • Diseases
    • Genetics
    • Mind & Brain
    • Nutrition
  • Future
  • Space
  • Feature
    • Feature Post
    • Art
    • Great Pics
    • Design
    • Fossil Friday
    • AstroPicture
    • GeoPicture
    • Did you know?
    • Offbeat
  • More
    • About
    • The Team
    • Advertise
    • Contribute
    • Our stance on climate change
    • Privacy Policy
    • Contact
No Result
View All Result
ZME Science

No Result
View All Result
ZME Science
No Result
View All Result
Home Health & Medicine

New revolutionary antibody neutralizes 91% of HIV strains

Mihai Andrei by Mihai Andrei
March 11, 2013
in Health & Medicine, Research

Finally, it seems researchers have taken a new strong step towards developing an HIV vaccine, which could send HIV on the road to hell, so to speak. Researchers at the National Institute of Health (NIH) announced their discovery of three new HIV antibodies; this in itself is not big news, because HIV antibodies get discovered all the time. However, until now, the strongest one neutralized less than half of all HIV strains.

Yet one of these three antibodies kills no less than 91% of all HIV strains, which makes it by far the best one so far. New techniques for rapidly identifying antibodies allowed the discovery of numerous very potent ones. The researched spawned so much interest that it was published in two different papers in Science (here and here).

These new antibodies were found in the blood of an HIV positive man dubbed Donor 45, in the scientific research they published. Donor 45 is quite special, in that he is what you call a long-term nonprogressor, meaning he has been living with HIV for 20 years, without developing his condition. Despite the fact that he has the standard HIV load, his antibodies keep the virus from invading his cells. Researchers believe these antibodies are not the result of any special genes and they hope that anybody could produce them.

The next step would be producing a vaccine from the antibodies, but this is no easy task. Generating a HIV vaccine first requires creating a harmless version of the virus that can be safely induced in the body, and this is especially hard when it comes to HIV, because when in its dead form, it loses the capacity to generate an antibody response. However, hard doesn’t mean impossible. The process is delicate and requires some creative thinking, but the initial results show great promise for the future.

Get more science news like this...

Join the ZME newsletter for amazing science news, features, and exclusive scoops. More than 40,000 subscribers can't be wrong.

   

Picture source

Tags: aidsdiseasehivhiv vaccine
Mihai Andrei

Mihai Andrei

Andrei's background is in geophysics, and he's been fascinated by it ever since he was a child. Feeling that there is a gap between scientists and the general audience, he started ZME Science -- and the results are what you see today.

Follow ZME on social media

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
  • Coronavirus
  • News
  • Environment
  • Health
  • Future
  • Space
  • Feature
  • More

© 2007-2019 ZME Science - Not exactly rocket science. All Rights Reserved.

No Result
View All Result
  • Coronavirus
  • News
  • Environment
    • Climate
    • Animals
    • Renewable Energy
    • Eco tips
    • Environmental Issues
    • Green Living
  • Health
    • Alternative Medicine
    • Anatomy
    • Diseases
    • Genetics
    • Mind & Brain
    • Nutrition
  • Future
  • Space
  • Feature
    • Feature Post
    • Art
    • Great Pics
    • Design
    • Fossil Friday
    • AstroPicture
    • GeoPicture
    • Did you know?
    • Offbeat
  • More
    • About
    • The Team
    • Advertise
    • Contribute
    • Our stance on climate change
    • Privacy Policy
    • Contact

© 2007-2019 ZME Science - Not exactly rocket science. All Rights Reserved.